nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefalotin—SLC22A5—Dactinomycin—testicular cancer	0.367	0.367	CbGbCtD
Cefalotin—SLC22A11—Methotrexate—testicular cancer	0.193	0.193	CbGbCtD
Cefalotin—SLC22A7—Methotrexate—testicular cancer	0.184	0.184	CbGbCtD
Cefalotin—SLC22A8—Methotrexate—testicular cancer	0.112	0.112	CbGbCtD
Cefalotin—SLC22A6—Methotrexate—testicular cancer	0.078	0.078	CbGbCtD
Cefalotin—ALB—Methotrexate—testicular cancer	0.0665	0.0665	CbGbCtD
